SCHEMBL21292826

SCHEMBL21292826

CNC(=S)NN=Cc1ccc(-c2ccc(C(=O)O)cc2)o1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 1.00
MAPT P10636 4/20 1.00
NPC1 O15118 3/20 1.00
POLB P06746 3/20 1.00
TDP1 Q9NUW8 3/20 1.00
PKM P14618 2/20 1.00
HSP90AA1 P07900 1/20 1.00
APEX1 P27695 1/20 1.00
L3MBTL1 Q9Y468 1/20 1.00
PHGDH O43175 7/20 0.80
RAB9A P51151 2/20 0.76
KEAP1 Q14145 1/20 0.73
NFE2L2 Q16236 1/20 0.73
LDHA P00338 1/20 0.61
ALDH1A1 P00352 3/20 0.59
HPGD P15428 2/20 0.59
MEN1 O00255 2/20 0.58
KMT2A Q03164 2/20 0.58
LMNA P02545 2/20 0.58
GAA P10253 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21292824 1.00 KDM4E (1.00) KDM4EMAPTNPC1POLBTDP1
SCHEMBL21292822 0.89 PHGDH (1.00) KDM4EMAPTNPC1POLBTDP1
SCHEMBL20115432 0.89 PHGDH (1.00) KDM4EMAPTNPC1POLBTDP1
SCHEMBL28369229 0.88 KEAP1 (0.85) KDM4EMAPTNPC1POLBTDP1
SCHEMBL28369230 0.88 KEAP1 (0.85) KDM4EMAPTNPC1POLBTDP1
SCHEMBL21292810 0.87 PHGDH (1.00) KDM4EMAPTNPC1POLBTDP1
SCHEMBL20115438 0.87 PHGDH (1.00) KDM4EMAPTNPC1POLBTDP1
SCHEMBL13611637 0.86 MAPT (0.75) KDM4EMAPTNPC1POLBTDP1
SCHEMBL4459314 0.86 MAPT (0.75) KDM4EMAPTNPC1POLBTDP1
SCHEMBL21292800 0.85 PHGDH (0.75) KDM4EMAPTNPC1POLBTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10722489-B2 D-3-phosphoglycerate dehydrogenase allosteric inhibitor and use thereof PEKING UNIVERSITY (CN) 2020-07-28 US disclosed
US-20200054593-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF UNIV BEIJING (CN) 2020-02-20 US disclosed
US-20190262303-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF UNIV BEIJING (CN) 2019-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10722489-B2 D-3-phosphoglycerate dehydrogenase allosteric inhibitor and use thereof MDH2, MDH1, DLD KDM4E 1863/4885MAPT 3785/4885NPC1 4801/4885
US-20200054593-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF MDH2, MDH1, DLD KDM4E 1863/4885MAPT 3785/4885NPC1 4801/4885
US-20190262303-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF MDH2, MDH1, DLD KDM4E 1863/4885MAPT 3785/4885NPC1 4801/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.